Crinetics Pharmaceuticals, Inc. ( CRNX) - Key Metrics
CRNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.24 | -$1.14 | -$0.89 | -$0.90 |
| 2026Q1 | $0.10 | -$1.23 | -$1.20 | -$1.21 |
| 2025Q4 | $0.07 | -$1.31 | -$0.99 | -$0.99 |
| 2025Q3 | $0 | -$1.38 | -$1.18 | -$1.18 |
| 2025Q2 | $0.01 | -$1.23 | -$0.92 | -$0.95 |
CRNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.21 |
| 2026Q1 | 0% | -7.38 |
| 2025Q4 | 0% | -8.95 |
| 2025Q3 | 0% | -7.55 |
| 2025Q2 | 0% | -5.85 |
CRNX
Price: $84.70
52 week price:
Earnings Per Share: -5.05 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 265100
Market Capitalization: 8.9 billion